- Category
- Micro (2023-24)
- Udyam number
- UDYAM-WB-13-0035039

Ranfa Pharmaceuticals Private Limited
About Ranfa Pharmaceuticals Private Limited
Data last updated:
Ranfa Pharmaceuticals Private Limited is a private limited company based in Taltala, West Bengal, India. It operates in the manufacturing segment of the healthcare sector. It was incorporated on 01 February 2022.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U33119WB2022PTC251285.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Ariba Siddique and Mohd Nazrul Islam.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 41/2 Gardner Lane 3rd Floor, Flat – 3E Taltala, West Bengal, India – 700014.
As per the financials filed for FY 2025, the company reported a revenue of ₹17.56 Lakh, a growth of 149% compared to the previous year. For the same year it recorded a net profit of ₹1.15 Lakh (net margin 6.6%) and EBITDA of ₹1.56 Lakh (EBITDA margin 8.9%).
Ranfa Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-13-0035039). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Ranfa Pharmaceuticals
Contact details
Ranfa Pharmaceuticals Private Limited's registered office is in Taltala, West Bengal.
- Registered Address41/2 Gardner Lane 3rd Floor, Flat – 3E Taltala, West Bengal, India – 700014
- IndustryHealthcare, Manufacturing, Other Medical And Surgical Equipment, Medical & Surgical Equipment, Orthopedic Appliances, Medical Appliances And Instruments
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ranfa Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Ranfa Pharmaceuticals Private Limited, buy the company report.
Financials of Ranfa Pharmaceuticals Private Limited
FY 2025 filings availableRanfa Pharmaceuticals Private Limited reported revenue of ₹17.56 Lakh (up 149% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 149% in the latest year. EBITDA rose 76% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹1.56 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹1.15 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 8.9% | |||
| Net Profit Margin | 6.6% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Ranfa Pharmaceuticals Private Limited, buy the company report.
Board of directors of Ranfa Pharmaceuticals Private Limited
Ranfa Pharmaceuticals has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ariba Siddique | Director | 01 Feb 2022 | 4 Years 8 Months | Current |
| Mohd Nazrul Islam | Director | 01 Feb 2022 | 4 Years 8 Months | Current |
| Rubeda Hamid | Director | 01 Feb 2022 | 4 Years 8 Months | Current |
| Runi Khatun | Additional Director | 01 Apr 2023 | 3 Years 6 Months | Current |
Peer comparison
Ranfa Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Victomed Pharmaceuticals Private Limited | ₹17.58 Lakh (FY 2025) | -2.0% | Theni, Tamil Nadu, India | |||
| Bioscodex Pharmaceuticals Private Limited | ₹17.57 Lakh (FY 2019) | 93.0% | Hyderabad, Telangana, India | |||
| Ranfa Pharmaceuticals Private Limitedthis company | ₹17.56 Lakh (FY 2025) | ₹1.15 Lakh | 6.6% | 149.0% | Taltala, West Bengal, India | |
| Agbro Pharmaceuticals Private Limited | ₹17.53 Lakh (FY 2021) | -28.0% | Bangalore, Karnataka, India | |||
| Indie Globe Pharmaceuticals Private Limited | ₹17.5 Lakh (FY 2016) | 9.0% | New Delhi, Delhi, India |
To see the full peer comparison of Ranfa Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ranfa Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ranfa Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Ranfa Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Ranfa Pharmaceuticals Private Limited has 4 board changes on record since 2022: 4 appointments. The latest: Runi Khatun was appointed as Additional Director on 01 Apr 2023.
Frequently asked questions
Ranfa Pharmaceuticals is an active private limited company based in Taltala, West Bengal, India. The company works in manufacturing, within the healthcare industry. It was incorporated on 01 February 2022 (4+ years old) and is registered under CIN U33119WB2022PTC251285.
Ranfa Pharmaceuticals has 4 current directors:
- Ariba Siddique - Director
- Mohd Nazrul Islam - Director
- Rubeda Hamid - Director
- Runi Khatun - Additional Director
The latest financial statements of Ranfa Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Ranfa Pharmaceuticals is U33119WB2022PTC251285. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ranfa Pharmaceuticals was incorporated on 01 February 2022, making it 4+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Ranfa Pharmaceuticals by revenue are Victomed Pharmaceuticals Private Limited, Bioscodex Pharmaceuticals Private Limited, Agbro Pharmaceuticals Private Limited, Indie Globe Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Runi Khatun was appointed as Additional Director on 01 Apr 2023. Ariba Siddique was appointed as Director on 01 Feb 2022. Mohd Nazrul Islam was appointed as Director on 01 Feb 2022. Ranfa Pharmaceuticals has 4 board changes on record in total.
Yes, Ranfa Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-WB-13-0035039).
The registered office of Ranfa Pharmaceuticals is at 412 Gardner Lane 3rd Floor, Flat – 3E Taltala, West Bengal, India – 700014.
Ranfa Pharmaceuticals operates in the healthcare industry, in the manufacturing segment.
The compliance status of Ranfa Pharmaceuticals is compliant as of 11 August 2026. The company is actively filing with the Registrar of Companies.